{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T08:48:40Z","timestamp":1777798120468,"version":"3.51.4"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,10,6]],"date-time":"2013-10-06T00:00:00Z","timestamp":1381017600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/s00277-013-1913-z","type":"journal-article","created":{"date-parts":[[2013,10,5]],"date-time":"2013-10-05T03:29:09Z","timestamp":1380943749000},"page":"677-682","source":"Crossref","is-referenced-by-count":22,"title":["Impact of the duration of antiviral prophylaxis on rates of varicella-zoster virus reactivation disease in autologous hematopoietic cell transplantation recipients"],"prefix":"10.1007","volume":"93","author":[{"given":"Quoc","family":"Truong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Veltri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abraham S.","family":"Kanate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanqing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Craig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Hamadani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron","family":"Cumpston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,10,6]]},"reference":[{"key":"1913_CR1","unstructured":"Su SH, Martel-Lafferriere V, Labbe A, Snydman DR, Kent D, Laverdiere M, et al. (2011) High incidence of herpes zoster in nonmyeloablative hematopoietic stem cell transplantation. Biol Blood Marrow Transplant [epub]:1\u20137"},{"issue":"4","key":"1913_CR2","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1182\/blood.V74.4.1424.1424","volume":"74","author":"LM Shuchter","year":"1989","unstructured":"Shuchter LM, Wingard JR, Piantadosi S, Burns WH, Santos GW, Saral R (1989) Herpes zoster infection after autologous bone marrow transplantation. Blood 74(4):1424\u20131427","journal-title":"Blood"},{"key":"1913_CR3","first-page":"495","volume":"10","author":"A Sempere","year":"1992","unstructured":"Sempere A, Sanz GF, Senent L, de la Rubia J, Jarque I, Lopez F et al (1992) Long-term acyclovir prophylaxis for prevention of varicella zoster virus infection after autologous blood stem cell transplantation in patients with acute leukemia. Bone Marrow Transplant 10:495\u2013498","journal-title":"Bone Marrow Transplant"},{"key":"1913_CR4","unstructured":"National Comprehensive Cancer Network Inc. Prevention and treatment of cancer-related infections. Version 1.2012. Available from http:\/\/www.nccn.org\/professionals\/physician_gls\/PDF\/infections.pdf . Accessed 15 Jan 2013"},{"issue":"6a","key":"1913_CR5","first-page":"659","volume":"6","author":"CDC","year":"2000","unstructured":"CDC, Infectious Disease Society of America, American Society of Blood and Marrow Transplantation (2000) Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients: recommendations of CDC, the Infectious Disease Society of America, and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant 6(6a):659\u2013713","journal-title":"Biol Blood Marrow Transplant"},{"key":"1913_CR6","first-page":"185","volume":"1","author":"P Ljungman","year":"1986","unstructured":"Ljungman P, Wilczek H, Gahrton G, Gustavsson A, Lundgren G, L\u00f6nnqvist B et al (1986) Long term acyclovir prophylaxis in bone marrow transplant recipients and lymphocyte proliferation responses to herpes virus antigens in vitro. Bone Marrow Transplant 1:185\u2013192","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"1913_CR7","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1182\/blood-2007-03-077644","volume":"110","author":"V Erard","year":"2007","unstructured":"Erard V, Guthrie KA, Varley C, Heugel J, Wald A, Flowers ME et al (2007) One year acyclovir prophylaxis for preventing varicella zoster virus disease after hematopoietic cell transplantation: no evidence of rebound varicella-zoster virus disease after drug discontinuation. Blood 110(8):3071\u20133077","journal-title":"Blood"},{"issue":"29","key":"1913_CR8","doi-asserted-by":"crossref","first-page":"4784","DOI":"10.1200\/JCO.2007.14.9641","volume":"26","author":"A Channan-Khan","year":"2008","unstructured":"Channan-Khan A, Sonneveld P, Schuster MW, Stadtmauer EA, Facon T, Harousseau JL et al (2008) Analysis of herpes zoster events among bortezomib-treated patients in the phase III APEX study. J Clin Oncology 26(29):4784\u20134790","journal-title":"J Clin Oncology"},{"key":"1913_CR9","unstructured":"Center for Disease Control and Prevention. Available from http:\/\/www.cdc.gov\/shingles\/lab-testing\/collecting-specimens.html . Accessed 15Jan 2013"},{"issue":"3","key":"1913_CR10","doi-asserted-by":"crossref","first-page":"274","DOI":"10.4065\/84.3.274","volume":"84","author":"P Sampathkumar","year":"2009","unstructured":"Sampathkumar P, Drage LA, Martin DP (2009) Herpes zoster (shingles) and postherpetic neuralgia. Mayo Clin Proc 84(3):274\u2013280","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"1913_CR11","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.bbmt.2009.03.003","volume":"15","author":"M Onozawa","year":"2009","unstructured":"Onozawa M, Hashino S, Haseyama Y, Hirayama Y, Iizuka S, Ishida T et al (2009) Incidence and risk of postherpetic neuralgia after varicella zoster virus infection in hematopoietic cell transplantation recipients: Hokkaido Hematology Study Group. Biol Blood Marrow Transplant 15(6):724\u2013729","journal-title":"Biol Blood Marrow Transplant"},{"key":"1913_CR12","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1083-8791(00)70004-8","volume":"6","author":"AM Arvin","year":"2000","unstructured":"Arvin AM (2000) Varicella-zoster virus: pathogenesis, immunity, and clinical management in hematopoietic cell transplant recipients. Biol Blood Marrow Transplant 6:219\u2013230","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"1913_CR13","first-page":"277","volume":"13","author":"CS Han","year":"1994","unstructured":"Han CS, Miller W, Haake R, Weisdorf D (1994) Varicella zoster infection after bone marrow transplantation: incidence, risk factors and complications. Bone Marrow Transplant 13(3):277\u2013283","journal-title":"Bone Marrow Transplant"},{"key":"1913_CR14","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/sj.bmt.1702119","volume":"25","author":"TF Leung","year":"2000","unstructured":"Leung TF, Chik KW, Li CK, Lai H, Shing MM, Chan PK et al (2000) Incidence, risk factors and outcome of varicella-zoster virus infection in children after haematopoietic stem cell transplantation. Bone Marrow Transplant 25:167\u2013172","journal-title":"Bone Marrow Transplant"},{"key":"1913_CR15","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/bmt.2008.384","volume":"43","author":"GL Uy","year":"2009","unstructured":"Uy GL, Goyal SD, Fisher NM, Oza AY, Tomasson MH, Stockerl-Goldstein K et al (2009) Bortezomib administer pre-auto-SCT and as maintenance therapy post transplant for multiple myeloma: a single institution phase II study. Bone Marrow Transplant 43:793\u2013800","journal-title":"Bone Marrow Transplant"},{"key":"1913_CR16","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1182\/blood-2006-04-019778","volume":"108","author":"MV Mateos","year":"2006","unstructured":"Mateos MV, Hern\u00e1ndez JM, Hern\u00e1ndez MT, Guti\u00e9rrez NC, Palomera L, Fuertes M et al (2006) Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: results of a multicenter phase 1\/2 study. Blood 108:2165\u20132172","journal-title":"Blood"},{"key":"1913_CR17","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/cncr.24006","volume":"115","author":"E Vickrey","year":"2008","unstructured":"Vickrey E, Allen S, Mehta J, Singhal S (2008) Acyclovir to prevent reactivation of varicella zoster virus (herpes zoster) in multiple myeloma patients receiving bortezomib therapy. Cancer 115:229\u2013232","journal-title":"Cancer"},{"key":"1913_CR18","unstructured":"A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Participants Undergoing Hematopoietic Cell Transplants (HCTs) (Study No. V212-001 AM4). Available from http:\/\/clinicaltrials.gov . Accessed 15 Jan 2013."}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-013-1913-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-013-1913-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-013-1913-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T09:32:01Z","timestamp":1596619921000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-013-1913-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,6]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["1913"],"URL":"https:\/\/doi.org\/10.1007\/s00277-013-1913-z","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,6]]}}}